4
Changes in Ownership
Adaptive Biotechnologies Corp Filed Acc 0001209191-21-018737
SVP, Diagnostics, clonoSEQ acquired 9,158 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| BOBULSKY SUSAN SVP, Diagnostics, clonoSEQ | 2021-03-04 | Grant or award | +9,158 | 9,158 | D: show line 1 in the form |
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| BOBULSKY SUSAN SVP, Diagnostics, clonoSEQ | 2021-03-04 | Grant or award · Stock Option (Right to Buy) | +22,894 | 22,894 | D: show line 2 in the form |
Loading xslF345X03/doc4.xml…